Brain activity associated with attention deficits following chemotherapy for childhood acute lymphoblastic leukemia

Keyphrases

• Brain Activity 100%
• Chemotherapy 100%
• Functional Magnetic Resonance Imaging 100%
• Survivors 100%
• Methotrexate 100%
• Attention Deficit 100%
• Childhood Acute Lymphoblastic Leukemia 100%
• Attention Network Task 100%
• Continuous Performance Task 100%
• Executive Function 66%
• Neurocognitive Testing 66%
• Brain Activation 66%
• Parietal Lobe 66%
• Attention Function 66%
• Caudate 33%
• Hippocampus 33%
• High Dose 33%
• Insula 33%
• Young Age 33%
• Age at Diagnosis 33%
• Serum Concentration 33%
• Statistical Test 33%
• Intravenous Injection 33%
• Task Performance 33%
• Cognitive Deficits 33%
• Temporal Lobe 33%
• Chemotherapy Exposure 33%
• Frontal Lobe 33%
• Brain Function 33%
• Image Analysis 33%
• Neurocognitive Dysfunction 33%
• Neural Substrates 33%
• Multi-task 33%
• Chemotherapy Treatment 33%
• Task Activation 33%
• Anterior Cingulate 33%
• Population Norms 33%
• Treatment Intensity 33%
• Sustained Attention 33%
• Mapping Tool 33%
• Cognitive Flexibility 33%
• Compensatory Changes 33%
• Statistical Parametric Mapping 33%
• Acute Lymphoblastic Leukemia Survivors 33%
• Right Temporal 33%
• Central Nervous System Activity 33%

Neuroscience

• Functional Magnetic Resonance Imaging 100%
• Attention Deficit Hyperactivity Disorder 100%
• Methotrexate 100%
• Continuous Performance Task 100%
• Electroencephalogram 100%
• Brain Activation 66%
• Parietal Lobe 66%
• Executive Function 66%
• Hippocampus 33%
• Cognitive Disorders 33%
• Central Nervous System 33%
• Frontal Lobe 33%
• Temporal Lobe 33%
• Brain Function 33%
• Cognitive Flexibility 33%
• Statistical Parametric Mapping 33%